Maxio Robot
Accelerated design meets FDA readiness in just 6 months
Fast-tracked industrial design of Perfint’s first oncology robot
Concurrent DfX to ensure critical timeframe to FDA submission
Completed Summative Test within 6 months
• Perfint (spinoff of Medtronic India) needed a US-based design partner to help commercialize their feasibility prototype within a compressed schedule to maintain funding for the start-up client
• BH leveraged user-experience with surgical robots to refine the engineering prototype with limited initial exposure to contextual needs
• Design team paired simultaneous industrial and mechanical design to develop a Beta prototype CAD database in only 4 weeks
• Combined BH-Perfint team collaborated to develop the HFE Summative Test protocol and to collect DfX feedback while the Beta unit was being assembled to finalize the commercial design
• Usability Validation activities were executed and successfully submitted to the FDA within six calendar months.
